Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

19.16 +9.70 (+102.54%)
Official Closing Price Updated: 8:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Dow Surges 100 Points; Target Shares Fall After Q2 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Wednesday's pre-market session: top gainers and losers ↗
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Soars 66% In Pre-Market On $6 Million Investment Deal, CEO Appointment ↗
NovaBay Pharmaceuticals Inc. jumps 66.57% to $1 in pre-market trading after major investment and leadership changes prevent liquidation. 
Via Benzinga
News headline image
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
Get insights into the top gainers and losers of Friday's pre-market session. ↗
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
From NovaBay Pharmaceuticals
Via Business Wire
News headline image
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
From NovaBay Pharmaceuticals
Via Business Wire
News headline image
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
What's Going On With NovaBay Pharmaceuticals Shares Friday? ↗
NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals. 
Via Benzinga
News headline image
NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
What's Going On With NovaBay Pharmaceuticals (NBY) Stock? ↗
NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering. 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60% ↗
NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering. 
Via Benzinga
News headline image
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>